 Mean Annualized Bleed Rate Reduced by 80 from Baseline and Factor VIII Usage Reduced by 94 in Year 3 Compared to Baseline 92 of Patients off Prophylaxis at the End of Year 3 First Outcomes-Based Agreement OBA Recently Signed in Germany; Additional Agreements Expected to be Signed in Coming Weeks ...... 